136 related articles for article (PubMed ID: 19386361)
1. Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma.
Seker M; Bilici A; Ustaalioglu BO; Salman T; Sonmez B; Canpolat NA; Salepci T; Gumus M; Yaylaci M
Leuk Res; 2009 Sep; 33(9):e154-6. PubMed ID: 19386361
[No Abstract] [Full Text] [Related]
2. Unusual cystic presentation of pulmonary nodular amyloidosis associated with MALT-type lymphoma.
Lantuejoul S; Moulai N; Quetant S; Brichon PY; Brambilla C; Brambilla E; Ferretti GR
Eur Respir J; 2007 Sep; 30(3):589-92. PubMed ID: 17766635
[TBL] [Abstract][Full Text] [Related]
3. Small-cell lung cancer arising after chemotherapy for a patient with lymphoma of pulmonary mucosa-associated lymphoid tissue-a case report.
Nakao M; Oguri T; Maeno K; Kusumoto S; Ota C; Takakuwa O; Uemura T; Ozasa H; Iwashima Y; Miyazaki M; Kutsuna T; Nakamura A; Inagaki H; Sato S; Ueda R
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1711-4. PubMed ID: 19838033
[TBL] [Abstract][Full Text] [Related]
4. Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma.
Okamura I; Imai H; Mori K; Ogura K; Isoda A; Mihara K; Matsumoto M; Saito R; Takahashi T; Ikeda T
Int J Hematol; 2015 Jan; 101(1):46-51. PubMed ID: 25378228
[TBL] [Abstract][Full Text] [Related]
5. Regression of pulmonary MALT lymphoma after treatment with rituximab.
Chong EA; Svoboda J; Cherian S; Andreadis C; Downs LH; Zhuang H; Alavi A; Tsai DE; Schuster SJ
Leuk Lymphoma; 2005 Sep; 46(9):1383-6. PubMed ID: 16109620
[TBL] [Abstract][Full Text] [Related]
6. Treatment of localized oral MALT lymphoma by rituximab: a case report.
Yamagata K; Onizawa K; Kojima H; Yoshida H
Oral Maxillofac Surg; 2008 Dec; 12(4):227-30. PubMed ID: 18830723
[TBL] [Abstract][Full Text] [Related]
7. Rituximab-induced remission of a gastric MALT lymphoma.
Datta YH; Kampalath B; Binion DG
Leuk Lymphoma; 2004 Jun; 45(6):1297-9. PubMed ID: 15360017
[TBL] [Abstract][Full Text] [Related]
8. Intralesional rituximab for primary iris lymphoma.
Demirci H; Grant JS; Elner VM
JAMA Ophthalmol; 2015 Jan; 133(1):104-5. PubMed ID: 25211092
[No Abstract] [Full Text] [Related]
9. t(11;18)(q21;q21)-positive advanced-stage MALT lymphoma associated with monoclonal gammopathy: resistance to rituximab or rituximab-containing chemotherapy.
Ohno H; Isoda K
J Clin Exp Hematop; 2008 Nov; 48(2):47-54. PubMed ID: 19039196
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximab.
Morgensztern D; Rosado MF; Serafini AN; Lossos IS
Leuk Lymphoma; 2004 Jun; 45(6):1275-8. PubMed ID: 15360012
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary BALT lymphoma successfully treated with eight cycles weekly rituximab: report of first case and F-18 FDG PET/CT images.
Bilici A; Seker M; Ustaalioglu BB; Canpolat N; Salepci T; Gumus M
J Korean Med Sci; 2011 Apr; 26(4):574-6. PubMed ID: 21468267
[TBL] [Abstract][Full Text] [Related]
12. [Successful rituximab monotherapy in a patient with mucosa-associated lymphoid tissue lymphoma of the rectum with trisomy 3, 18].
Kagawa M; Okamura S; Okamoto K; Kitamura S; Kimura T; Niki M; Kaji M; Okahisa T; Yano M; Kagawa S; Kudo E; Sano T; Imoto Y; Wada S; Takayama T
Nihon Shokakibyo Gakkai Zasshi; 2010 Apr; 107(4):612-9. PubMed ID: 20379095
[TBL] [Abstract][Full Text] [Related]
13. [Pulmonary MALT lymphoma revealing AIDS].
Cortot AB; Cottin V; Issartel B; Meyronet D; Coiffier B; Cordier JF
Rev Mal Respir; 2006 Sep; 23(4 Pt 1):353-7. PubMed ID: 17127912
[TBL] [Abstract][Full Text] [Related]
14. Rituximab for the treatment of extranodal marginal zone B-cell lymphoma of the lacrimal gland.
Heinz C; Merz H; Nieschalk M; Mueller-Miny H; Koch P; Heiligenhaus A
Br J Ophthalmol; 2007 Nov; 91(11):1563-4. PubMed ID: 17947275
[No Abstract] [Full Text] [Related]
15. [Pulmonary MALT lymphoma with macroglobulinemia].
Takasaki H; Takabayashi M; Yamaji S; Koharazawa H; Fujimaki K; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2005 Feb; 46(2):144-6. PubMed ID: 16447709
[TBL] [Abstract][Full Text] [Related]
16. Transformation of MALT lymphoma to pure plasma cell histology following treatment with the anti-CD20 antibody rituximab.
Woehrer S; Streubel B; Chott A; Hoffmann M; Raderer M
Leuk Lymphoma; 2005 Nov; 46(11):1645-9. PubMed ID: 16236618
[TBL] [Abstract][Full Text] [Related]
17. [Mucosa-associated lymphoid tissue (MALT) lymphoma of the lung treated by surgery and rituximab; report of a case].
Yoshida C; Tarumi S; Kato A; Nii K; Chang SS; Yokomise H
Kyobu Geka; 2013 Feb; 66(2):169-72. PubMed ID: 23381369
[TBL] [Abstract][Full Text] [Related]
18. Transformation of MALT lymphoma to pure plasma cell histology: possible association with anti-CD20 antibody treatment.
Klein N; Elis A; Radnay J; Zemer R; Klein A; Lishner M
Isr Med Assoc J; 2009 Nov; 11(11):703-4. PubMed ID: 20108563
[No Abstract] [Full Text] [Related]
19. Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren's syndrome.
Harner KC; Jackson LW; Drabick JJ
Rheumatology (Oxford); 2004 Oct; 43(10):1309-10. PubMed ID: 15448217
[No Abstract] [Full Text] [Related]
20. Very good partial response in a patient with MALT-lymphoma of the lung after treatment with low-dose thalidomide.
Kees M; Raderer M; Metz-Schimmerl S; Chott A; Gisslinger H
Leuk Lymphoma; 2005 Sep; 46(9):1379-82. PubMed ID: 16109619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]